Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer.
Shabbir Muhammad Husayn AlibhaiHenriette BreunisAaron Richard HansenRichard GreggPadraig WardeNarhari TimilshinaGeorge TomlinsonAnthony M JoshuaSebastien HotteNeil FleshnerUrban EmmeneggerPublished in: Cancer (2021)
There is external validation of the CARG tool in predicting grade 3+ toxicity in older men with mCRPC undergoing CHEMO and demonstrated utility during A/E therapy. This may aid with treatment decision-making.